Currency in USD
Earnings estimate | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|
No. of analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | 1.02 | 0.45 | 3.52 | 3.74 |
Low estimate | 1.02 | 0.45 | 3.07 | 3.24 |
High estimate | 1.02 | 0.45 | 4.12 | 4.44 |
Year ago EPS | 1.26 | 0.86 | 3.89 | 3.52 |
Revenue estimate | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|
No. of analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 8.56B | 8.04B | 33.48B | 33.95B |
Low estimate | 8.4B | 7.9B | 32.65B | 32.08B |
High estimate | 8.71B | 8.17B | 33.93B | 35.22B |
Year ago sales | N/A | 12.84B | 46.91B | 33.48B |
Sales growth (year/est) | N/A | -37.40% | -28.60% | 1.40% |
Earnings history | 29/09/2021 | 30/12/2021 | 30/03/2022 | 29/06/2022 |
---|
Est. EPS | 1.01 | 0.81 | 0.92 | 0.73 |
Actual EPS | 1.26 | 0.86 | 1.09 | 0.87 |
Difference | 0.25 | 0.05 | 0.17 | 0.14 |
Surprise % | 24.80% | 6.20% | 18.50% | 19.20% |
EPS trend | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|
Current estimate | 1.02 | 0.45 | 3.52 | 3.74 |
7 days ago | 1.02 | 0.45 | 3.52 | 3.74 |
30 days ago | 0.83 | 0.79 | 3.22 | 3.48 |
60 days ago | 0.83 | 0.79 | 3.23 | 3.47 |
90 days ago | 0.83 | 0.79 | 3.24 | 3.48 |
EPS revisions | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | 1 | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 1 | 1 | 2 | 2 |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -19.00% | N/A | N/A | N/A |
Next qtr. | -47.70% | N/A | N/A | N/A |
Current year | -9.50% | N/A | N/A | N/A |
Next year | 6.30% | N/A | N/A | N/A |
Next 5 years (per annum) | 10.80% | N/A | N/A | N/A |
Past 5 years (per annum) | -0.40% | N/A | N/A | N/A |